Literature DB >> 28694920

Role of microglia in methamphetamine-induced neurotoxicity.

Enquan Xu1, Jianuo Liu1, Han Liu1, Xiaobei Wang2, Huangui Xiong1.   

Abstract

Methamphetamine (Meth) is an addictive psychostimulant widely abused around the world. The chronic use of Meth produces neurotoxicity featured by dopaminergic terminal damage and microgliosis, resulting in serious neurological and behavioral consequences. Ample evidence indicate that Meth causes microglial activation and resultant secretion of pro-inflammatory molecules leading to neural injury. However, the mechanisms underlying Meth-induced microglial activation remain to be determined. In this review, we attempt to address the effects of Meth on human immunodeficiency virus (HIV)-associated microglia activation both in vitro and in-vivo. Meth abuse not only increases HIV transmission but also exacerbates progression of HIV-associated neurocognitive disorders (HAND) through activation of microglia. In addition, the therapeutic potential of anti-inflammatory drugs on ameliorating Meth-induced microglia activation and resultant neuronal injury is discussed.

Entities:  

Keywords:  Drug abuse; methamphetamine; microglia; neuroinflammation; neurotoxicity

Year:  2017        PMID: 28694920      PMCID: PMC5498881     

Source DB:  PubMed          Journal:  Int J Physiol Pathophysiol Pharmacol        ISSN: 1944-8171


  177 in total

1.  Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs.

Authors:  S Czub; E Koutsilieri; S Sopper; M Czub; C Stahl-Hennig; J G Müller; V Pedersen; W Gsell; J L Heeney; M Gerlach; G Gosztonyi; P Riederer; V ter Meulen
Journal:  Acta Neuropathol       Date:  2001-02       Impact factor: 17.088

Review 2.  Physiology of microglia.

Authors:  Helmut Kettenmann; Uwe-Karsten Hanisch; Mami Noda; Alexei Verkhratsky
Journal:  Physiol Rev       Date:  2011-04       Impact factor: 37.312

3.  SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation.

Authors:  Matthew J Robson; Ryan C Turner; Zachary J Naser; Christopher R McCurdy; James P O'Callaghan; Jason D Huber; Rae R Matsumoto
Journal:  Exp Neurol       Date:  2014-02-06       Impact factor: 5.330

4.  Microglial activation and chronic neurodegeneration.

Authors:  Melinda E Lull; Michelle L Block
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

5.  Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules.

Authors:  Ikuko Miyazaki; Masato Asanuma; Francisco J Diaz-Corrales; Masaya Fukuda; Kiyoyuki Kitaichi; Ko Miyoshi; Norio Ogawa
Journal:  FASEB J       Date:  2006-01-10       Impact factor: 5.191

6.  Methamphetamine decreases CD4 T cell frequency and alters pro-inflammatory cytokine production in a model of drug abuse.

Authors:  Mariana M Mata; T Celeste Napier; Steven M Graves; Fareeha Mahmood; Shohreh Raeisi; Linda L Baum
Journal:  Eur J Pharmacol       Date:  2015-02-10       Impact factor: 4.432

Review 7.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

8.  Methamphetamine causes microglial activation in the brains of human abusers.

Authors:  Yoshimoto Sekine; Yasuomi Ouchi; Genichi Sugihara; Nori Takei; Etsuji Yoshikawa; Kazuhiko Nakamura; Yasuhide Iwata; Kenji J Tsuchiya; Shiro Suda; Katsuaki Suzuki; Masayoshi Kawai; Kiyokazu Takebayashi; Shigeyuki Yamamoto; Hideo Matsuzaki; Takatoshi Ueki; Norio Mori; Mark S Gold; Jean L Cadet
Journal:  J Neurosci       Date:  2008-05-28       Impact factor: 6.167

9.  Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice.

Authors:  Hiroyuki Mizoguchi; Kazuhiro Takuma; Ayumi Fukakusa; Yukio Ito; Akiko Nakatani; Daisuke Ibi; Hyoung-Chun Kim; Kiyofumi Yamada
Journal:  Psychopharmacology (Berl)       Date:  2007-10-02       Impact factor: 4.530

10.  Alteration of Methamphetamine-induced stereotypic behaviour in transgenic mice expressing HIV-1 envelope protein gp120.

Authors:  Amanda J Roberts; Ricky Maung; Natalia E Sejbuk; Christopher Ake; Marcus Kaul
Journal:  J Neurosci Methods       Date:  2009-11-13       Impact factor: 2.390

View more
  15 in total

1.  Methamphetamine Impairs IgG1-Mediated Phagocytosis and Killing of Cryptococcus neoformans by J774.16 Macrophage- and NR-9640 Microglia-Like Cells.

Authors:  Lilit Aslanyan; Hiu H Lee; Vaibhav V Ekhar; Raddy L Ramos; Luis R Martinez
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

Review 2.  Non-coding RNA: insights into the mechanism of methamphetamine neurotoxicity.

Authors:  Ying-Jian Gu; Lei Chen; Lin Cheng; Ming-Yuan Zhou; Yun Wang
Journal:  Mol Cell Biochem       Date:  2021-04-25       Impact factor: 3.396

3.  Effect of methamphetamine on the fasting blood glucose in methamphetamine abusers.

Authors:  Yanhong Zhang; Guofang Shu; Ying Bai; Jie Chao; Xufeng Chen; Honghong Yao
Journal:  Metab Brain Dis       Date:  2018-06-26       Impact factor: 3.584

Review 4.  Laminin as a Biomarker of Blood-Brain Barrier Disruption under Neuroinflammation: A Systematic Review.

Authors:  Juan F Zapata-Acevedo; Valentina García-Pérez; Ricardo Cabezas-Pérez; Monica Losada-Barragán; Karina Vargas-Sánchez; Rodrigo E González-Reyes
Journal:  Int J Mol Sci       Date:  2022-06-17       Impact factor: 6.208

5.  Methamphetamine alters the TLR4 signaling pathway, NF-κB activation, and pro-inflammatory cytokine production in LPS-challenged NR-9460 microglia-like cells.

Authors:  Ana M Vargas; Dormarie E Rivera-Rodriguez; Luis R Martinez
Journal:  Mol Immunol       Date:  2020-03-26       Impact factor: 4.407

6.  Methamphetamine Induces Apoptosis of Microglia via the Intrinsic Mitochondrial-Dependent Pathway.

Authors:  Anna V Sharikova; Elizabeth Quaye; Jun Yong Park; Maxwell C Maloney; Habben Desta; Ramkumar Thiyagarajan; Kenneth L Seldeen; Neil U Parikh; Parteet Sandhu; Alexander Khmaladze; Bruce R Troen; Stanley A Schwartz; Supriya D Mahajan
Journal:  J Neuroimmune Pharmacol       Date:  2018-04-11       Impact factor: 4.147

Review 7.  Contribution of TSPO imaging in the understanding of the state of gliosis in substance use disorders.

Authors:  Claire Leroy; Wadad Saba
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-27       Impact factor: 9.236

Review 8.  Microglia Gone Rogue: Impacts on Psychiatric Disorders across the Lifespan.

Authors:  Tuan Leng Tay; Catherine Béchade; Ivana D'Andrea; Marie-Kim St-Pierre; Mathilde S Henry; Anne Roumier; Marie-Eve Tremblay
Journal:  Front Mol Neurosci       Date:  2018-01-04       Impact factor: 5.639

Review 9.  The Main Molecular Mechanisms Underlying Methamphetamine- Induced Neurotoxicity and Implications for Pharmacological Treatment.

Authors:  Xue Yang; Yong Wang; Qiyan Li; Yaxian Zhong; Liangpei Chen; Yajun Du; Jing He; Lvshuang Liao; Kun Xiong; Chun-Xia Yi; Jie Yan
Journal:  Front Mol Neurosci       Date:  2018-06-04       Impact factor: 5.639

Review 10.  Neurotoxicity of methamphetamine: Main effects and mechanisms.

Authors:  Subramaniam Jayanthi; Atul P Daiwile; Jean Lud Cadet
Journal:  Exp Neurol       Date:  2021-06-26       Impact factor: 5.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.